These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26289249)

  • 1. Cardiomyogenic differentiation of human sternal bone marrow mesenchymal stem cells using a combination of basic fibroblast growth factor and hydrocortisone.
    Hafez P; Jose S; Chowdhury SR; Ng MH; Ruszymah BH; Abdul Rahman Mohd R
    Cell Biol Int; 2016 Jan; 40(1):55-64. PubMed ID: 26289249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction.
    Wang X; Zhen L; Miao H; Sun Q; Yang Y; Que B; Lopes Lao EP; Wu X; Ren H; Shi S; Lau WB; Ma X; Ma C; Nie S
    Theranostics; 2015; 5(9):995-1006. PubMed ID: 26155315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
    Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
    J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural maturation of human bone marrow mesenchymal stem cells-derived cardiomyocytes under alternative induction of 5-azacytidine.
    Piryaei A; Soleimani M; Heidari MH; Saheli M; Rohani R; Almasieh M
    Cell Biol Int; 2015 May; 39(5):519-30. PubMed ID: 25573851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
    Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
    Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic fibroblast growth factor is a key factor that induces bone marrow mesenchymal stem cells towards cells with Schwann cell phenotype.
    Zhu H; Yang A; Du J; Li D; Liu M; Ding F; Gu X; Liu Y
    Neurosci Lett; 2014 Jan; 559():82-7. PubMed ID: 24309293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovine fetal mesenchymal stem cell differentiation to cardiomyocytes, effects of co-culture, role of small molecules; reversine and 5-azacytidine.
    Soltani L; Rahmani HR; Daliri Joupari M; Ghaneialvar H; Mahdavi AH; Shamsara M
    Cell Biochem Funct; 2016 Jun; 34(4):250-61. PubMed ID: 27121349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differences between adipose-derived stem cells and mesenchymal stem cells in differentiation into cardiomyocytes].
    Zhang DZ; Gai LY; Liu HW
    Sheng Li Xue Bao; 2008 Jun; 60(3):341-7. PubMed ID: 18560724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function.
    Shinmura D; Togashi I; Miyoshi S; Nishiyama N; Hida N; Tsuji H; Tsuruta H; Segawa K; Tsukada Y; Ogawa S; Umezawa A
    Stem Cells; 2011 Feb; 29(2):357-66. PubMed ID: 21732492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed enrichment for c-kit and inducing cardiac differentiation attenuated protective effects of BMSCs' transplantation in pig model of acute myocardial ischemia.
    Zhang GW; Gu TX; Guan XY; Sun XJ; Jiang DQ; Tang R; Qi X; Li XY
    Cardiovasc Ther; 2015 Aug; 33(4):184-92. PubMed ID: 25959676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rehmannia glutinosa oligosaccharide induces differentiation of bone marrow mesenchymal stem cells into cardiomyocyte-like cells.
    Wang XH; Du HW; Guo XH; Wang SW; Zhou RB; Li Y; Li ZB; Zhao YS; Zhu QL
    Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27813551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesis.
    Numasawa Y; Kimura T; Miyoshi S; Nishiyama N; Hida N; Tsuji H; Tsuruta H; Segawa K; Ogawa S; Umezawa A
    Stem Cells; 2011 Sep; 29(9):1405-14. PubMed ID: 21755575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFβ1 contributes to cardiomyogenic-like differentiation of human bone marrow mesenchymal stem cells.
    Mohanty S; Bose S; Jain KG; Bhargava B; Airan B
    Int J Cardiol; 2013 Feb; 163(1):93-9. PubMed ID: 21903280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear cardiac troponin and tropomyosin are expressed early in cardiac differentiation of rat mesenchymal stem cells.
    Asumda FZ; Chase PB
    Differentiation; 2012 Mar; 83(3):106-15. PubMed ID: 22364878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient cardiomyogenic differentiation of bone marrow mesenchymal stromal cells by combination of Wnt11 and bone morphogenetic protein 2.
    Zhang Z; Li H; Ma Z; Feng J; Gao P; Dong H; Zhang Z
    Exp Biol Med (Maywood); 2012 Jul; 237(7):768-76. PubMed ID: 22829700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic differentiation of human bone marrow-derived mesenchymal stem cells by tetracycline-regulated hepatocyte nuclear factor 3beta.
    Ishii K; Yoshida Y; Akechi Y; Sakabe T; Nishio R; Ikeda R; Terabayashi K; Matsumi Y; Gonda K; Okamoto H; Takubo K; Tajima F; Tsuchiya H; Hoshikawa Y; Kurimasa A; Umezawa A; Shiota G
    Hepatology; 2008 Aug; 48(2):597-606. PubMed ID: 18666263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bFGF on HLA-DR expression of human bone marrow-derived mesenchymal stem cells.
    Dighe PA; Viswanathan P; Mruthunjaya AK; Seetharam RN
    J Stem Cells; 2013; 8(1):43-57. PubMed ID: 24459812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of induction of cardiomyocyte differentiation for in vitro cultured mesenchymal stem cells: a perspective for emergencies.
    Tokcaer-Keskin Z; Akar AR; Ayaloglu-Butun F; Terzioglu-Kara E; Durdu S; Ozyurda U; Ugur M; Akcali KC
    Can J Physiol Pharmacol; 2009 Feb; 87(2):143-50. PubMed ID: 19234578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium.
    Bartunek J; Croissant JD; Wijns W; Gofflot S; de Lavareille A; Vanderheyden M; Kaluzhny Y; Mazouz N; Willemsen P; Penicka M; Mathieu M; Homsy C; De Bruyne B; McEntee K; Lee IW; Heyndrickx GR
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1095-104. PubMed ID: 17056665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential.
    Siegel G; Krause P; Wöhrle S; Nowak P; Ayturan M; Kluba T; Brehm BR; Neumeister B; Köhler D; Rosenberger P; Just L; Northoff H; Schäfer R
    Stem Cells Dev; 2012 Sep; 21(13):2457-70. PubMed ID: 22309203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.